Recent News

• 04.01.2025 - Capricor Therapeutics to Present at the 2025 Piper Sandler Virtual Cardio Day
• 04.01.2025 - Capricor Therapeutics to Present at the 2025 Piper Sandler Virtual Cardio Day
• 03.19.2025 - Capricor Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
• 03.19.2025 - Capricor Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
• 03.17.2025 - Capricor Therapeutics Announces Positive Data Demonstrating Long-Term Efficacy of Deramiocel for the Treatment of Duchenne Muscular Dystrophy
• 03.17.2025 - Capricor Therapeutics Announces Positive Data Demonstrating Long-Term Efficacy of Deramiocel for the Treatment of Duchenne Muscular Dystrophy
• 03.11.2025 - Capricor Therapeutics to Present Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Update on March 19
• 03.11.2025 - Capricor Therapeutics to Present Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Update on March 19
• 03.07.2025 - Capricor Therapeutics to Present at Leerink’s Global Healthcare Conference 2025
• 03.07.2025 - Capricor Therapeutics to Present at Leerink’s Global Healthcare Conference 2025

Recent Filings

• 03.26.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.19.2025 - EX-99.1 EX-99.1
• 03.19.2025 - 8-K Current report
• 03.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.04.2025 - 8-K Current report
• 03.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.04.2025 - EX-99.1 EX-99.1
• 03.04.2025 - 4 Statement of changes in beneficial ownership of securities